TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32319392

Group type: EXPERIMENTAL
Intervention: Low-dose bortezomib (0.7 mg/m2) + cyclophosphamide (0.5 g/m2) + dexamethasone
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Standard-dose bortezomib (1.3 mg/m2) + cyclophosphamide (0.5 g/m2) + dexamethasone
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Bortezomib (0.7 mg/m2) + dexamethasone
Number of subjects: 58

Group type: COMPARATOR
Intervention: Low-dose bortezomib-based therapy
Number of subjects: 58

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 58
Study: 33904666

Group type: EXPERIMENTAL
Intervention: Follicular flushing with double lumen needles (Wallace DNS1733)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Direct aspiration with single lumen needles (Wallace ONS1733)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Follicular flushing
Number of subjects: 208

Group type: COMPARATOR
Intervention: Direct aspiration
Number of subjects: 208
Study: 35875695

Group type: EXPERIMENTAL
Intervention: Dihydrocapsiate (12 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 32452284

Group type: EXPERIMENTAL
Intervention: Passive hip joint mobilization
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo mobilization
Number of subjects: 18
Study: 35172775

Group type: EXPERIMENTAL
Intervention: PROLACT intervention
Number of subjects: 434

Group type: COMPARATOR
Intervention: Usual practice (Control)
Number of subjects: 434
Study: 33954881

Group type: EXPERIMENTAL
Intervention: Enhanced violence screening model
Number of subjects: 2621

Group type: COMPARATOR
Intervention: Routine screening
Number of subjects: 2621
Study: 32512248

Group type: EXPERIMENTAL
Intervention: A‐PDT
Number of subjects: 60

Group type: COMPARATOR
Intervention: CPG
Number of subjects: 60
Study: 36152013

Group type: EXPERIMENTAL
Intervention: Non-cultured epidermal cell suspension (ECS)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Hair follicle cell suspension (HFCS)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: ECS
Number of subjects: 74

Group type: COMPARATOR
Intervention: HFCS
Number of subjects: 74
Study: 33215986

Group type: EXPERIMENTAL
Intervention: 6-month recall
Number of subjects: 2372

Group type: EXPERIMENTAL
Intervention: risk-based recall
Number of subjects: 2372

Group type: EXPERIMENTAL
Intervention: 24-month recall
Number of subjects: 2372
Study: 34236011

Group type: EXPERIMENTAL
Intervention: GB222 (1 mg/kg)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Bevacizumab (1 mg/kg)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: GB222
Number of subjects: 84

Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 84
Study: 33471112

Group type: EXPERIMENTAL
Intervention: MTX monotherapy
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Restarting golimumab treatment
Number of subjects: 25

Group type: COMPARATOR
Intervention: Step-down strategy to MTX monotherapy
Number of subjects: 25
Study: 35724518

Group type: EXPERIMENTAL
Intervention: Enhanced single-theme CWLs with varying textual and pictorial components
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: Enhanced single-theme CWLs with pictorial components
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: Pictorially enhanced CWLs
Number of subjects: 523

Group type: COMPARATOR
Intervention: Currently required CWLs in California
Number of subjects: 523
Study: 33832100

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine
Number of subjects: 78

Group type: COMPARATOR
Intervention: Hair shaving
Number of subjects: 78
Study: 35552463

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 35
Study: 32241619

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 4796

Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 4796
Study: 35328990

Group type: EXPERIMENTAL
Intervention: Amino acid and hyaluronic acid-based gel
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no product used)
Number of subjects: 40
Study: 32100647

Group type: EXPERIMENTAL
Intervention: Multi-nutrient (1 g DHA, 160 mg EPA, 240 mg Ginkgo biloba, 60 mg phosphatidylserine, 20 mg d‐α tocopherol, 1 mg folic acid and 20 g vitamin B12 per day)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Multi-nutrient and exercise (spin class twice per week)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Exercise and placebo
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 34807983

Group type: EXPERIMENTAL
Intervention: GVAX
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study: 32792079

Group type: EXPERIMENTAL
Intervention: MAP 80/85 to 100 mm Hg target
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Higher doses of norepinephrine and dobutamine
Number of subjects: 120

Group type: COMPARATOR
Intervention: MAP 65 mm Hg target
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Additional pharmacologic support
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Survival with good neurologic outcome at 180 days
Number of subjects: 120
Study: 36321193

Group type: EXPERIMENTAL
Intervention: Clinical Breast Examination (CBE)
Number of subjects: 59447

Group type: COMPARATOR
Intervention: Control (no screening)
Number of subjects: 59447
Study: 33656786

Group type: EXPERIMENTAL
Intervention: Medium AMF availability
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High AMF availability
Number of subjects: 0

Group type: COMPARATOR
Intervention: Zero AMF availability
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AMF availability
Number of subjects: 0
Study: 32416385

Group type: EXPERIMENTAL
Intervention: Transdiagnostic preventative intervention focused on reduction of safety aids
Number of subjects: 69

Group type: COMPARATOR
Intervention: Health focused control group
Number of subjects: 69
Study: 35320813

Group type: EXPERIMENTAL
Intervention: Tongue-pressure resistance training (TPRT) for 20 min/day in addition to traditional swallowing rehabilitation for 30 min/day for 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional swallowing rehabilitation for 30 min/day for 4 weeks
Number of subjects: 0
Study: 32785768

Group type: EXPERIMENTAL
Intervention: RADPEER 1
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: RADPEER 2
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: RADPEER 3
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: RADPEER 1-2
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Distal PDAC
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Stage IV
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: No surgery
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Surgical patients
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 257
Study: 35985545

Group type: EXPERIMENTAL
Intervention: ETV+BRC
Number of subjects: 1000

Group type: COMPARATOR
Intervention: ETV monotherapy
Number of subjects: 1000

Group type: COMPARATOR
Intervention: ETV+BRC and ETV monotherapy
Number of subjects: 1000
Study: 34732148

Group type: EXPERIMENTAL
Intervention: Multicomponent exercise intervention (60-min sessions, twice a week for 6 months)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 43
Study: 32744872

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral intervention for test anxiety (six sessions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study: 33270707

Group type: EXPERIMENTAL
Intervention: Kola genotypes (A12, JB4, JB19, JB36, P2-1b, P2-1c) identified for phenolic traits selection
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Kola genotypes (A10, Club, Atta1, JB10) identified for soluble and insoluble sugar-rich variety development
Number of subjects: 25
Study: 36104016

Group type: EXPERIMENTAL
Intervention: Adaptive support ventilation (ASV)
Number of subjects: 226
Study: 32392574

Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 32481369

Group type: EXPERIMENTAL
Intervention: Proximal adductor canal block (PACB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Distal adductor canal block (DACB)
Number of subjects: 0
Study: 36344827

Group type: EXPERIMENTAL
Intervention: Informational booklet with 4-session support intervention
Number of subjects: 66

Group type: COMPARATOR
Intervention: Informational booklet without 4-session support intervention
Number of subjects: 66
Study: 35080127

Group type: EXPERIMENTAL
Intervention: Cryopreserved bioactive split thickness skin allograft (BSA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard of care (SOC, collagen alginate dressing)
Number of subjects: 100
Study: 34323596

Group type: EXPERIMENTAL
Intervention: Dileucine (2g)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Leucine (2g)
Number of subjects: 10
Study: 33283151

Group type: EXPERIMENTAL
Intervention: Wearable technology (Fitbit Charge 2) with personalised text message feedback and goal setting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wearable technology (Fitbit Charge 2) without feedback (active comparator)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups will be re-assessed at 12 weeks and 24 weeks
Number of subjects: 0
Study: 36047026

Group type: EXPERIMENTAL
Intervention: No drain
Number of subjects: 90

Group type: COMPARATOR
Intervention: Drain
Number of subjects: 90
Study: 33107209

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation program (12-week training and exercise program including walking sessions at home at least three times a week)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation program
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70
Study: 33915788

Group type: EXPERIMENTAL
Intervention: Modified low-protein formula (mLP) (1.7 g protein/100 kcal)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Control formula (CTRL) (2.1 g protein/100 kcal)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Breast-fed (BF)
Number of subjects: 133
Study: 32406265

Group type: EXPERIMENTAL
Intervention: Keep Safe intervention
Number of subjects: 100
Study: 33306026

Group type: EXPERIMENTAL
Intervention: Drink Less app with daily 11 AM notification
Number of subjects: 19233

Group type: EXPERIMENTAL
Intervention: Drink Less app
Number of subjects: 19233
Study: 35128872

Group type: EXPERIMENTAL
Intervention: Acupoint-penetrating needling technique of acupuncture and enema with tuihuang mixture
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine western medicine treatment and enema with tuihuang mixture
Number of subjects: 120
Study: 32092472

Group type: EXPERIMENTAL
Intervention: Oral bambuterol hydrochloride (10 mg, once daily, for 3 days)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 42
Study: 35383114

Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg Q2W)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Nivolumab (240 mg Q2W)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Nivolumab (1 mg/kg) + Ipilimumab (3 mg/kg Q3W for four doses then nivolumab 240 mg Q2W)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 243
Study: 34634097

Group type: EXPERIMENTAL
Intervention: SPELL (base intervention)
Number of subjects: 7076

Group type: EXPERIMENTAL
Intervention: SPELL+PD (enhanced version with professional development for teachers)
Number of subjects: 7076

Group type: EXPERIMENTAL
Intervention: SPELL+HOME (enhanced version with home-based program for parents)
Number of subjects: 7076

Group type: COMPARATOR
Intervention: BAU (business as usual)
Number of subjects: 7076

Group type: EXPERIMENTAL
Intervention: Moderation analyses for children with mothers having low-mid education
Number of subjects: 7076
Study: 32300055

Group type: EXPERIMENTAL
Intervention: Personalised, trauma-informed yoga (n=10)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Group-format fitness (n=8)
Number of subjects: 21
Study: 34185752

Group type: EXPERIMENTAL
Intervention: Psychological counseling combined with outdoor exercise
Number of subjects: 160

Group type: COMPARATOR
Intervention: Routine in-campus education of health knowledge
Number of subjects: 160
Study: 34797038

Group type: EXPERIMENTAL
Intervention: Parent-only psychoeducational intervention
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Hands-on parent training in a naturalistic developmental intervention
Number of subjects: 86
Study: 34091607

Group type: EXPERIMENTAL
Intervention: Supervised core stability exercise programme
Number of subjects: 30

Group type: COMPARATOR
Intervention: Unsupervised, home-based core stability exercise programme
Number of subjects: 30
Study: 33293804

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) point of care guided approach
Number of subjects: 386

Group type: COMPARATOR
Intervention: Sputum color assessment
Number of subjects: 386
Study: 35055470

Group type: EXPERIMENTAL
Intervention: Group intervention program to foster resilience over eight weeks
Number of subjects: 72

Group type: COMPARATOR
Intervention: Wait list control condition
Number of subjects: 72
Study: 33396887

Group type: EXPERIMENTAL
Intervention: Genetically determined serum 25(OH)D
Number of subjects: 307618

Group type: EXPERIMENTAL
Intervention: Genetic liability to depression
Number of subjects: 307618

Group type: COMPARATOR
Intervention: Higher 25(OH)D concentrations
Number of subjects: 307618
Study: 36117204

Group type: EXPERIMENTAL
Intervention: Physiotherapy combined with HILT (n=14)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Physiotherapy combined with ESWT (n=14)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Physiotherapy alone (n=14)
Number of subjects: 42
Study: 33763127

Group type: EXPERIMENTAL
Intervention: Vibration applied to MCPJ digit 3 at 60 Hz and amplitude of 2 mm
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Vibration applied to MCPJ digit 5
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 100% supramaximal stimulus intensity
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Cessation of vibration stimulation
Number of subjects: 19
Study: 34383222

Group type: EXPERIMENTAL
Intervention: Inhalation of 7% sodium chloride solution
Number of subjects: 644

Group type: COMPARATOR
Intervention: Control group (coughing up sputum as usual)
Number of subjects: 644
Study: 32071118

Group type: EXPERIMENTAL
Intervention: Nelipepimut-S (NPS) with GM-CSF
Number of subjects: 275

Group type: COMPARATOR
Intervention: Placebo with GM-CSF (control)
Number of subjects: 275
Study: 616389246

Group type: EXPERIMENTAL
Intervention: Oro-Pharyngeal airway cap (OPLAC)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Endotracheal Intubation (ETT)
Number of subjects: 86
Study: 35803723

Group type: EXPERIMENTAL
Intervention: Endovascular thrombectomy (EVT)
Number of subjects: 299
Study: 33587897

Group type: EXPERIMENTAL
Intervention: Bedaquiline
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Delamanid
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Bedaquiline plus Delamanid
Number of subjects: 84
Study: 32249850

Group type: EXPERIMENTAL
Intervention: 20 mg lutein supplementation (beeswax group)
Number of subjects: 39

Group type: COMPARATOR
Intervention: 20 mg lutein supplementation (glycerol fatty acid esters group)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both groups (beeswax and glycerol fatty acid esters)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Consumption of green vegetables
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 39
Study: 34274687

Group type: EXPERIMENTAL
Intervention: Interactive Stepping Exercise (ISE)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Home Exercise Program (Control)
Number of subjects: 14
Study: 32363411

Group type: EXPERIMENTAL
Intervention: FRIENDS program (intervention group)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 280
Study: 35378068

Group type: EXPERIMENTAL
Intervention: Alirocumab (75 mg by subcutaneous injection every 2 weeks)
Number of subjects: 18924

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18924

Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 18924
Study: 34015046

Group type: EXPERIMENTAL
Intervention: Nurse-led anticipatory care planning intervention
Number of subjects: 34

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 34
Study: 32758455

Group type: EXPERIMENTAL
Intervention: Debio 1143 (200 mg per day on days 1-14 of 21-day cycles, for three cycles)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo (20 mg/mL, administered at the same dosing schedule)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Debio 1143
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 35421030

Group type: EXPERIMENTAL
Intervention: Purpose-design underpants
Number of subjects: 31

Group type: COMPARATOR
Intervention: Conventional underpants
Number of subjects: 31
Study: 34454572

Group type: EXPERIMENTAL
Intervention: Nilavembu Kudineer (NVK)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Kaba Sura Kudineer (KSK)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo (decaffeinated tea)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: All groups (NVK, KSK, and placebo)
Number of subjects: 125
Study: 35803632

Group type: EXPERIMENTAL
Intervention: Community-wide mass drug administration (cMDA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: School-based deworming (SBD)
Number of subjects: 0
Study: 33431147

Group type: EXPERIMENTAL
Intervention: Complex school-based intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (current practice)
Number of subjects: 40
Study: 34144489

Group type: EXPERIMENTAL
Intervention: Endometriomas with peritoneal endometriosis
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Endometriomas with deep infiltrating endometriosis
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Endometriomas with both peritoneal and deep infiltrating endometriosis
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Unilateral endometriomas
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Bilateral endometriomas
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Unilateral adnexal adhesions in bilateral endometriomas
Number of subjects: 310
Study: 33213532

Group type: EXPERIMENTAL
Intervention: Women who committed to pay dowry upon marriage
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Women who suspected their husbands of having extramarital affairs
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Women who reported having poor spousal communication
Number of subjects: 250
Study: 34753540

Group type: EXPERIMENTAL
Intervention: High-dose caffeine (10 mg/kg maintenance dose)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Low-dose caffeine (5 mg/kg maintenance dose)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 162
Study: 32588685

Group type: EXPERIMENTAL
Intervention: Asymmetric transcranial direct current stimulation (tDCS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo sham group
Number of subjects: 0
Study: 34411802

Group type: EXPERIMENTAL
Intervention: Vernix caseosa
Number of subjects: 64

Group type: COMPARATOR
Intervention: Mother's milk
Number of subjects: 64
Study: 32445503

Group type: COMPARATOR
Intervention: Sintering temperature at 1350°C
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Sintering temperature at 1450°C
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Sintering temperature at 1600°C
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Thickness of 1 mm
Number of subjects: 120

Group type: COMPARATOR
Intervention: Thickness of 1.5 mm
Number of subjects: 120
Study: 33826415

Group type: EXPERIMENTAL
Intervention: Combined treatment with IPC plus LLLT
Number of subjects: 42

Group type: COMPARATOR
Intervention: IPC therapy alone
Number of subjects: 42
Study: 33190242

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 81
Study: 32229444

Group type: EXPERIMENTAL
Intervention: Dinner at 21:00
Number of subjects: 8

Group type: COMPARATOR
Intervention: Dinner at 18:00
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Divided dinner (vegetable and rice at 18:00 and vegetable and the main dish at 21:00)
Number of subjects: 8
Study: 35334197

Group type: EXPERIMENTAL
Intervention: 4 mg baricitinib
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: 2 mg baricitinib
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1200

Group type: COMPARATOR
Intervention: 4 mg baricitinib vs Placebo
Number of subjects: 1200

Group type: COMPARATOR
Intervention: 2 mg baricitinib vs Placebo
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Baricitinib (4 mg)
Number of subjects: 1200
Study: 33099092

Group type: EXPERIMENTAL
Intervention: Back foot heel in full contact with the floor
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Back foot heel raised off the floor
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Back foot non weight bearing (NWB)
Number of subjects: 52
Study: 32843306

Group type: EXPERIMENTAL
Intervention: ERICA (Embryo Ranking Intelligent Classification Algorithm)
Number of subjects: 1231
Study: 35482101

Group type: EXPERIMENTAL
Intervention: Rotational atherectomy (RA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Balloon-based strategies
Number of subjects: 0
Study: 32648397

Group type: EXPERIMENTAL
Intervention: Needle-knife therapy at cervical spine area, acupuncture at specific acupoints, sodium hyaluronate eye drops (1 drop 5-6 times a day) for 3 courses (1 week each).
Number of subjects: 84

Group type: COMPARATOR
Intervention: Acupuncture at specific acupoints, sodium hyaluronate eye drops (1 drop 5-6 times a day) for 3 courses (1 week each).
Number of subjects: 84

Group type: COMPARATOR
Intervention: Sodium hyaluronate eye drops (1 drop 5-6 times a day) for 3 courses (1 week each).
Number of subjects: 84
Study: 33534859

Group type: EXPERIMENTAL
Intervention: Atezolizumab (anti-PD-L1)
Number of subjects: 941

Group type: COMPARATOR
Intervention: Chemotherapy arms
Number of subjects: 941
Study: 33197451

Group type: EXPERIMENTAL
Intervention: Glycerol
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Silicone oil
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Silica gel
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (Fresh lenticules)
Number of subjects: 90